WASHINGTON TRUST Co decreased its holdings in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 74.2% during the fourth quarter, Holdings Channel reports. The institutional investor owned 4,086 shares of the pharmacy operator’s stock after selling 11,741 shares during the quarter. WASHINGTON TRUST Co’s holdings in Walgreens Boots Alliance were worth $297,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also bought and sold shares of WBA. Hudock Capital Group LLC raised its stake in Walgreens Boots Alliance by 0.5% during the 2nd quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock worth $102,000 after acquiring an additional 6 shares during the period. Westside Investment Management Inc. raised its stake in Walgreens Boots Alliance by 10.4% during the 2nd quarter. Westside Investment Management Inc. now owns 1,325 shares of the pharmacy operator’s stock worth $102,000 after acquiring an additional 125 shares during the period. Zions Bancorporation raised its stake in Walgreens Boots Alliance by 983.3% during the 3rd quarter. Zions Bancorporation now owns 1,365 shares of the pharmacy operator’s stock worth $105,000 after acquiring an additional 1,239 shares during the period. IHT Wealth Management LLC raised its stake in Walgreens Boots Alliance by 46.3% during the 2nd quarter. IHT Wealth Management LLC now owns 6,946 shares of the pharmacy operator’s stock worth $135,000 after acquiring an additional 2,199 shares during the period. Finally, Bristlecone Advisors LLC bought a new stake in Walgreens Boots Alliance during the 3rd quarter worth approximately $135,000. 61.24% of the stock is currently owned by institutional investors.

In other Walgreens Boots Alliance news, insider Stefano Pessina purchased 98,858 shares of Walgreens Boots Alliance stock in a transaction that occurred on Monday, January 15th. The shares were bought at an average price of $76.07 per share, for a total transaction of $7,520,128.06. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 14.80% of the company’s stock.

A number of equities research analysts have commented on WBA shares. BidaskClub upgraded shares of Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research note on Friday, November 10th. Zacks Investment Research upgraded shares of Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $81.00 price objective on the stock in a research report on Wednesday, December 27th. Vetr upgraded shares of Walgreens Boots Alliance from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, December 12th. Robert W. Baird reiterated an “outperform” rating and set a $80.00 price objective (down previously from $90.00) on shares of Walgreens Boots Alliance in a research report on Thursday, October 19th. They noted that the move was a valuation call. Finally, Citigroup reduced their price objective on shares of Walgreens Boots Alliance from $95.00 to $81.00 and set a “buy” rating on the stock in a research report on Thursday, November 2nd. Eleven analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average target price of $85.53.

Shares of Walgreens Boots Alliance Inc (WBA) opened at $68.46 on Friday. Walgreens Boots Alliance Inc has a 1 year low of $63.82 and a 1 year high of $88.00. The firm has a market cap of $67,820.00, a price-to-earnings ratio of 18.91, a P/E/G ratio of 1.21 and a beta of 1.18. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.96 and a quick ratio of 0.47.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share for the quarter, topping the consensus estimate of $1.27 by $0.01. Walgreens Boots Alliance had a net margin of 3.19% and a return on equity of 19.15%. The company had revenue of $30.74 billion for the quarter, compared to analysts’ expectations of $30.39 billion. During the same quarter in the previous year, the business posted $1.10 earnings per share. Walgreens Boots Alliance’s quarterly revenue was up 7.9% on a year-over-year basis. analysts forecast that Walgreens Boots Alliance Inc will post 5.71 EPS for the current fiscal year.

Walgreens Boots Alliance announced that its Board of Directors has authorized a stock repurchase program on Wednesday, October 25th that allows the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization allows the pharmacy operator to reacquire shares of its stock through open market purchases. Stock repurchase programs are usually a sign that the company’s board believes its stock is undervalued.

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 12th. Investors of record on Thursday, February 15th will be given a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 2.34%. The ex-dividend date is Wednesday, February 14th. Walgreens Boots Alliance’s dividend payout ratio is presently 44.20%.

WARNING: This story was first reported by Daily Political and is the sole property of of Daily Political. If you are reading this story on another domain, it was stolen and reposted in violation of United States & international copyright law. The original version of this story can be accessed at https://www.dailypolitical.com/2018/02/10/washington-trust-co-reduces-position-in-walgreens-boots-alliance-inc-wba.html.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.